InsidersTradesSigma
Follow the Arovella Therapeutics Limited share price and the full management transaction log of the company, a listed issuer based in Australia. Shares are listed on the AU market, under the oversight of ASX. Operating in the Health Care sector, Arovella Therapeutics Limited has logged 3 reports. Market capitalisation: €72.5m. The latest transaction was reported on 9 June 2026 (Purchase). Among the most active insiders: Andrew Nash. All data is free.
3
Insider Decl.
n/a
Thresholds
€8,158
1 ops.
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,470 of 28,802 companies
34.9
score / 100
Value16
Quality53
FCF yld-9.3%
Earn yld-9.6%
EV/EBITDA·
ROE-40%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 June 2026
Declarations3 total
200,000 shares@ A$0.0670.0000% mcap100.0% of flowShareASXISIN AU0000182784ASX:2924-03098698-3A695000
ShareASXISIN AU0000182784ASX:2924-03087734-3A692891
●
11ASX ↗
ShareASXISIN AU0000182784ASX:2924-03085488-3A692486
3 of 3 declarations
About Arovella Therapeutics Limited
Arovella Therapeutics Limited is an Australian biopharmaceutical company focused on developing innovative treatments for serious diseases. It specializes in research and development of therapies based on advanced technologies.